Silence Therapeutics (SLN) Other Non-Current Assets (2023 - 2026)
Silence Therapeutics (SLN) reported Other Non-Current Assets of $127000.0 for Q1 2026, down 96.49% on a YoY basis from $3.6 million in Q1 2025, and little changed sequentially from $127000.0 in Q4 2025.
Silence Therapeutics (SLN) Other Non-Current Assets (2023 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 4 years of Other Non-Current Assets data on file, last reported at $127000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 96.49% year-over-year to $127000.0; the trailing twelve-month figure through Mar 2026 stood at $127000.0 (down 96.49% YoY), and the FY2025 full-year result was $127000.0, down 96.46% from the prior year.
- Other Non-Current Assets steadied at $127000.0 in Q1 2026, from $127000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $3.9 million in Q2 2025 to a low of $127000.0 in Q4 2025.
- A 4-year average of $2.1 million and a median of $3.2 million in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets increased 12.11% in 2024 and slumped 96.49% in 2026, its largest moves.
- Tracing SLN's Other Non-Current Assets over 4 years: stood at $3.2 million in 2023, then gained by 12.11% to $3.6 million in 2024, then slumped by 96.46% to $127000.0 in 2025, then changed by 0.0% to $127000.0 in 2026.
- Business Quant data shows SLN's Other Non-Current Assets at $127000.0 in Q1 2026, $127000.0 in Q4 2025, and $399000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 | 127,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127,000.00 |
| Dec 31, 2025 | 127,000.00 |
| Sep 30, 2025 | 399,000.00 |
| Jun 30, 2025 | 3.91 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 3.20 Mn |